Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Commensal Cross-Reactive T & B Cells Trigger Autoimmunity

Kurt Ullman  |  October 26, 2020

The hygiene hypothesis is the belief that exposure to infectious agents may help protect us from immune-related disorders, through antigenic competition, alterations in immunoregulation, and promotion of a Th1 vs. Th2 response. By decreasing our exposure to infections, antibiotics and improvements in hygiene may have increased our tendency to develop autoimmune diseases.

Mouse Model Gives Additional Information
Researchers also looked at a mouse model in which mice were exposed to R. intestinalis to induce β2GPI-specific lymphocytes and antibodies. As a control, they selected Bacteroides thetaiotaomicron (B. thetaiotaomicron). Lymphocytes from the spleen or peripheral lymph nodes of R. intestinalis mice proliferated more to recombinant human β2GPI than to B. thetaiotaomicron or sham-immunized mice.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

They next immunized mice with a R. intestinalis lysate (with Freund’s adjuvant) over 48 days to allow for a full antibody response to develop. Mice immunized with R. intestinalis had higher titers of serum anti-β2GPI IgG antibodies compared with controls. IgG antibodies to R. intestinalis DNA methyltranserfase (DNMT), containing the major APS B cell epitope, were also markedly increased compared to B. thetaiotaomicron or sham controls.

To determine if gut colonization with R. intestinalis would affect a rodent model with a genetic predisposition to spontaneously developing APS, they chose the (NZW x BXSB) male F1 hybrid mouse, which can develop an early, lupus-like disease. Deaths in this strain usually occur by 30 weeks because of anti-β2GPI autoantibody production leading to coronary microthrombi and myocardial infarctions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

All mice were treated with vancomycin prior to introduction of R. intestinalis. This treatment was done to prevent F1 mice from developing antibodies against other organisms in the microbiome, as well as to open a colonic niche for the human bacterium.

After pretreatment, investigators exposed the mice to fresh cultures of R. intestinalis or a sterile growth medium as a control. Autoantibody titers in mice infected with R. int were markedly above the titers observed in mice exposed to growth medium alone. Human anti-β2GPI IgG was positively correlated to anti-R. intestinalis DNA methyltransferase IgG similar to that seen in APS patient sera.

The researchers also noted that R. intestinalis exposed mice showed extensive inflammation in both the myocardium and subendocardium. This finding, along with lymphocytic infiltrates and necrosis, was not seen in controls that survived beyond 30 weeks. Lymphocytic infiltrates were also found in the lungs of the exposed mice, but not controls.

Genome & Microbiome Intertwined
“In some ways, the microbiome is not that much different from the host genome,” says Dr. Kriegel. “There are genetic risk factors in which we know a patient is predisposed to developing a given disease. It also appears there are some elements of the microbiome that make a person more susceptible to a disease, such as APS.”

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)Hughes SyndromeMicrobiomemicrobiota

Related Articles

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

    February 1, 2014

    With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

    Studies Find More Evidence the Microbiome Affects Autoimmune Disease

    August 17, 2018

    Evidence is accumulating that the microbiome may be an important part of the pathogenesis of many autoimmune diseases. Two recently published articles report on how translocation of the gut bacterium Enterococcus gallinarum drives autoimmunity in mice and humans, and on the role of other commensal bacteria in triggering immune responses—specifically to the autoantigen Ro60, which…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences